SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-003125
Filing Date
2021-01-12
Accepted
2021-01-11 20:42:26
Documents
7
Period of Report
2021-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm212718d1_6k.htm 6-K 10583
2 EXHIBIT 99.1 tm212718d1_ex99-1.htm EX-99.1 12758
3 EXHIBIT 99.2 tm212718d1_ex99-2.htm EX-99.2 12893
4 EXHIBIT 99.3 tm212718d1_ex99-3.htm EX-99.3 12434
5 EXHIBIT 99.4 tm212718d1_ex99-4.htm EX-99.4 372754
6 EXHIBIT 99.5 tm212718d1_ex99-5.htm EX-99.5 51877
7 GRAPHIC tm212718d1_ex99-3img01.jpg GRAPHIC 3304
  Complete submission text file 0001104659-21-003125.txt   479118
Mailing Address 610 - 700 WEST PENDER STREET VANCOUVER A1 V6C 1G8
Business Address 610 - 700 WEST PENDER STREET VANCOUVER A1 V6C 1G8 604-218-4766
Curaleaf Holdings, Inc. (Filer) CIK: 0001756770 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-249081 | Film No.: 21522167
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences